Literature DB >> 468370

Inactivation or elimination of potentially trypanolytic, complement-activating immune complexes by pathogenic trypanosomes.

A E Balber, J D Bangs, S M Jones, R L Proia.   

Abstract

Trypanosoma brucei subsp. brucei and T. congolense incubated in homologous antibody at 0 degrees C for 30 min were lysed by subsequent addition of guinea pig complement. Trypanosomes incubated in antibody at 37 degrees C before complement treatment remained intact. Parasites bearing adsorbed antibody also remained intact when incubated at 37 degrees C before complement treatment. The proportion of cells which survived complement treatment decreased with increasing antibody concentration. Parasites which survived complement treatment continued to express antigens which could bind complement-activating antibody, but did not bear complement-activating immune complexes. Virtually all cells in T. brucei populations exposed to antibody at 37 degrees C, but only 10(-3) to 10(-5) of the cells in populations exposed to antibody at 0 degrees C before complement treatment, remained infective for X-irradiated mice. Only 10(-6) to 10(-7) of T. brucei populations exposed to antibody at 0 or 37 degrees C before complement treatment infected mice immunized with homologous antigens. Serotype analysis of substrains and of T. brucei populations isolated from mice infected with antibody and complement-treated parasites suggested that variant-specific antigens participated in trypanolysis and that T. brucei which survived complement treatment could undergo antigenic variation. Mechanisms by which trypanosomes may inactivate or eliminate surface immune complexes and the possible significance of this phenomenon in trypanosomiasis are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468370      PMCID: PMC414351          DOI: 10.1128/iai.24.3.617-627.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  OBSERVATIONS ON ANTIGENIC VARIATION IN A STRAIN OF TRYPANOSOMA BRUCEI GROWING IN MICE.

Authors:  J F WATKINS
Journal:  J Hyg (Lond)       Date:  1964-03

2.  ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

Authors:  L J OLD; E A BOYSE
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

3.  A METHOD FOR THE MEASUREMENT OF THE INFECTIVITY OF TRYPANOSOME SUSPENSIONS.

Authors:  W H LUMSDEN; M P CUNNINGHAM; W A WEBBER; K VANHOEVE; P J WALKER
Journal:  Exp Parasitol       Date:  1963-12       Impact factor: 2.011

4.  The influence of antibody on serological variation in Trypanosoma brucei.

Authors:  A R GRAY
Journal:  Ann Trop Med Parasitol       Date:  1962-04

5.  The properties of some antigens of Trypanosoma brucei.

Authors:  B WEITZ
Journal:  J Gen Microbiol       Date:  1960-12

6.  Soluble antigens of Trypanosoma vivax and of other trypanosomes.

Authors:  A R GRAY
Journal:  Immunology       Date:  1961-07       Impact factor: 7.397

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Analysis of the antigenic composition of Trypanosoma brucei brucei bloodstream and culture forms by the quantitative direct fluorescent antibody methods.

Authors:  H A Stanley; B M Honigberg; I Cunningham
Journal:  J Protozool       Date:  1978-05

9.  Unusual antibody-induced modulation of surface antigens in the cell coat of a bloodstream trypanosome.

Authors:  M S Giannini; P A D'Alesandro
Journal:  Science       Date:  1978-09-08       Impact factor: 47.728

10.  Trypanosoma lewisi: immunoelectron microscopic studies on the surface antigens of bloodstream forms.

Authors:  P V Cherian; D G Dusanic
Journal:  Exp Parasitol       Date:  1977-10       Impact factor: 2.011

View more
  27 in total

1.  A determination of the steady state lysosomal pH of bloodstream stage African trypanosomes.

Authors:  Amanda K McCann; Kevin J Schwartz; James D Bangs
Journal:  Mol Biochem Parasitol       Date:  2008-02-15       Impact factor: 1.759

Review 2.  The trypanosome flagellar pocket.

Authors:  Mark C Field; Mark Carrington
Journal:  Nat Rev Microbiol       Date:  2009-10-06       Impact factor: 60.633

3.  Mechanisms for the elimination of potentially lytic complement-fixing variable surface glycoprotein antibody-complexes in Trypanosoma brucei.

Authors:  D C Russo; D J Williams; D J Grab
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

Review 4.  [African trypanosomes: parasites with protective mechanisms].

Authors:  H J Risse
Journal:  Naturwissenschaften       Date:  1988-10

5.  Rapid processing of the carboxyl terminus of a trypanosome variant surface glycoprotein.

Authors:  J D Bangs; D Hereld; J L Krakow; G W Hart; P T Englund
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Late endosomal Rab7 regulates lysosomal trafficking of endocytic but not biosynthetic cargo in Trypanosoma brucei.

Authors:  Jason S Silverman; Kevin J Schwartz; Stephen L Hajduk; James D Bangs
Journal:  Mol Microbiol       Date:  2011-09-30       Impact factor: 3.501

7.  Characterization of the late endosomal ESCRT machinery in Trypanosoma brucei.

Authors:  Jason S Silverman; Katherine A Muratore; James D Bangs
Journal:  Traffic       Date:  2013-08-18       Impact factor: 6.215

8.  Efficient introduction of plasmid DNA into Trypanosoma brucei and transcription of a transfected chimeric gene.

Authors:  J Eid; B Sollner-Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense.

Authors:  D V Devine; R J Falk; A E Balber
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi.

Authors:  U Frevert; S Schenkman; V Nussenzweig
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.